CIGNA CORPORATION

(CI)
  Report
Delayed Nyse  -  05/20 04:00:02 pm EDT
259.49 USD   +1.02%
05/20INSIDER SELL : Cigna
MT
05/20INSIDER SELL : Cigna
MT
05/16JPMorgan Raises Cigna to Overweight From Neutral, Price Target to $304 From $248
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Wells Fargo Upgrades Cigna to Overweight From Equalweight

01/06/2022 | 10:14am EDT


© MT Newswires 2022
All news about CIGNA CORPORATION
05/20INSIDER SELL : Cigna
MT
05/20INSIDER SELL : Cigna
MT
05/16JPMorgan Raises Cigna to Overweight From Neutral, Price Target to $304 From $248
MT
05/11TRANSCRIPT : Cigna Corporation Presents at Bank of America 2022 Healthcare Conference, May..
CI
05/10Raymond James Adjusts Cigna's Price Target to $300 From $275, Keeps Strong Buy Rating
MT
05/09Goldman Sachs Raises Cigna's Price Target to $273 From $239, Maintains Neutral Rating
MT
05/09Truist Securities Adjusts Cigna's Price Target to $310 from $290, Keeps Buy Rating
MT
05/09UBS Adjusts Cigna Price Target to $310 From $300, Maintains Buy Rating
MT
05/09WALL STREET STOCK EXCHANGE : We've had better days
05/09Oppenheimer Adjusts Cigna's Price Target to $310 From $300, Maintains Outperform Rating
MT
More news
Analyst Recommendations on CIGNA CORPORATION
More recommendations
Financials (USD)
Sales 2022 179 B - -
Net income 2022 5 236 M - -
Net Debt 2022 25 696 M - -
P/E ratio 2022 15,5x
Yield 2022 1,65%
Capitalization 82 329 M 82 329 M -
EV / Sales 2022 0,60x
EV / Sales 2023 0,57x
Nbr of Employees 72 963
Free-Float 79,5%
Chart CIGNA CORPORATION
Duration : Period :
Cigna Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CIGNA CORPORATION
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Last Close Price 259,49 $
Average target price 281,96 $
Spread / Average Target 8,66%
EPS Revisions
Managers and Directors
David Michael Cordani Chairman, President & Chief Executive Officer
Brian C. Evanko Chief Financial Officer & Executive Vice President
Noelle K. Eder Global Chief Information Officer & Executive VP
Paul Sanford Executive Vice President-Operations
William J. DeLaney Independent Director
Sector and Competitors
1st jan.Capi. (M$)
CIGNA CORPORATION13.00%82 329
UNITEDHEALTH GROUP-4.70%455 698
ANTHEM, INC.3.53%118 819
HUMANA INC.-6.87%55 609
CENTENE CORPORATION3.11%49 692
MOLINA HEALTHCARE, INC.-2.69%18 161